Sponsor or institution
Clinical trials and research at Nabiqasim Industries (Pvt) Ltd
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Nabiqasim Industries (Pvt) Ltd that are recruiting, in Pakistan. By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Resmetirom for MASH in Pakistani patients
This trial will test whether resmetirom is safe and helps adults in Pakistan with MASH who also have metabolic risk factors.
-
Single-pill combination of empagliflozin, linagliptin and metformin for blood sugar control
This test tries a single pill that combines empagliflozin, linagliptin, and metformin to lower blood sugar and simplify treatment for adults with type 2 diabetes who have HbA1c of 8% or higher and are already on two or more diabetes medicines.
Quick answers
How many clinical trials run by Nabiqasim Industries (Pvt) Ltd are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Pakistan. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.